References
- Zhang J, Walsh MF, Wu G, et al. Germline Mutations in Predisposition
Genes in Pediatric Cancer. N Engl J Med. 2015;373(24):2336-2346.
- Gröbner SN, Worst BC, Weischenfeldt J, et al. The landscape of genomic
alterations across childhood cancers. Nature. 2018;555(7696):321-327.
- Kratz CP, Jongmans MC, Cavé H, et al. Predisposition to cancer in
children and adolescents. Lancet Child Adolesc Health.
2021;5(2):142-154.
- Kim J, Gianferante M, Karyadi DM, et al. Frequency of Pathogenic
Germline Variants in Cancer-Susceptibility Genes in the Childhood
Cancer Survivor Study. JNCI Cancer Spectrum. 2021;5(2).
- Sylvester DE, Chen Y, Jamieson RV, Dalla-Pozza L, Byrne JA.
Investigation of clinically relevant germline variants detected by
next-generation sequencing in patients with childhood cancer: a review
of the literature. J Med Genet. 2018;55(12):785-793.
- Postema FAM, Hopman SMJ, Aalfs CM, et al. Childhood tumours with a
high probability of being part of a tumour predisposition syndrome;
reason for referral for genetic consultation. Eur J Cancer.
2017;80:48-54.
- Minh T, Nguyen K, Behnert A, et al. Proportion of children with cancer
that have an indication for genetic counseling and testing based on
the cancer type irrespective of other features. Fam Cancer.
2021;20:273-277.
- Druker H, Zelley K, McGee RB, Scollon SR, Kohlmann WK, Schneider KA,
Wolfe Schneider K. Genetic Counselor Recommendations for Cancer
Predisposition Evaluation and Surveillance in the Pediatric Oncology
Patient. Clin Cancer Res. 2017;23(13):e91–e97.
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the
interpretation of sequence variants: a joint consensus recommendation
of the American College of Medical Genetics and Genomics and the
Association for Molecular Pathology.Genet Med.2015;17:405–24.
- Postema FAM, Hopman SMJ, Hennekam RC, Merks JHM. Consequences of
diagnosing a tumor predisposition syndrome in children with cancer: A
literature review. Pediatr Blood Cancer. 2018;65(1).
- Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL. A practice
guideline from the American College of Medical Genetics and Genomics
and the National Society of Genetic Counselors: referral indications
for cancer predisposition assessment. Genet Med. 2015;17(1):70-87.
- Ripperger T, Bielack SS, Borkhardt A, et al. Childhood cancer
predisposition syndromes-A concise review and recommendations by the
Cancer Predisposition Working Group of the Society for Pediatric
Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017-1037.
- Jongmans MCJ, Loeffen JLCM, Waanders E, et al. Recognition of genetic
predisposition in pediatric cancer patients: An easy-to-use selection
tool. Eur J Med Genet. 2016;59(3):116-125.
- Goudie C, Coltin H, Witkowski L, Mourad S, Malkin D, Foulkes WD. The
McGill Interactive Pediatric OncoGenetic Guidelines: An approach to
identifying pediatric oncology patients most likely to benefit from a
genetic evaluation. Pediatr Blood Cancer. 2017;64(8):e26441.
- Cullinan N, Schiller I, di Giuseppe G, et al. Utility of a Cancer
Predisposition Screening Tool for Predicting Subsequent Malignant
Neoplasms in Childhood Cancer Survivors. J Clin Oncol.
2021;39(29):3207-3216.
- Goudie C, Witkowski L, Cullinan N, et al. Performance of the McGill
Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer
Predisposition Syndromes. JAMA Oncol. 2021;7(12):1.
- Rossini L, Durante C, Bresolin S, et al. Diagnostic strategies and
algorithms for investigating cancer predisposition syndromes in
children presenting with malignancy. Cancers. 2022;14(15):3741.
- Postema FAM, Hopman SMJ, de Borgie CAJM, et al. Clinical value of a
screening tool for tumor predisposition syndromes in childhood cancer
patients (TuPS): a prospective, observational, multi-center study. Fam
Cancer. 2021;20(4):263-271.
- Wagener R, Taeubner J, Walter C, et al. Comprehensive germline-genomic
and clinical profiling in 160 unselected children and adolescents with
cancer. Eur J Hum Genet. 2021;29(8):1301-1311.
- Gargallo P, Oltra S, Yáñez Y, et al. Germline Predisposition to
Pediatric Cancer, from Next Generation Sequencing to Medical Care.
Cancers. 2021;13(21).
- Fiala EM, Jayakumaran G, Mauguen A, et al. Prospective pan-cancer
germline testing using MSK-IMPACT informs clinical translation in 751
patients with pediatric solid tumors. Nat Cancer. 2021;2(3):357-365.
- Chan SH, Chew W, Ishak ND, et al. Clinical relevance of screening
checklists for detecting cancer predisposition syndromes in Asian
childhood tumours. npj Genomic Medicine. 2018;3(1).
- Byrjalsen A, Hansen TV, Stoltze UK, et al. Nationwide germline whole
genome sequencing of 198 consecutive pediatric cancer patients reveals
a high incidence of cancer prone syndromes. PLOS Genetics.
2020;16(12).
- Thariat J, Chevalier F, Orbach D, et al. Avoidance or adaptation of
radiotherapy in patients with cancer with Li-Fraumeni and heritable
TP53-related cancer syndromes. Lancet Oncol. 2021;22(12).
- Frebourg T, Bajalica Lagercrantz S, Oliveira C, et al. Guidelines for
the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum
Genet. 2020;28(10):1379-1386.
- Westdorp H, Kolders S, Hoogerbrugge N, et al. Immunotherapy holds the
key to cancer treatment and prevention in constitutional mismatch
repair deficiency (CMMRD) syndrome. Cancer Lett. 2017;403: 159-64.